Analyst · Bristol-Myers Squibb Company (BMY) | Ratings, Price Targets & Consensus

Analyst Consensus

Hold18 analysts

Hold

Updated Jul 30, 2026

Total Analysts18

Buy

19

Hold

20

Sell

2

Ratings

Updated Jul 30, 2026

Overall Rating

B+

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score3.0 / 5

ROA Score4.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$64.66

Median Target-8.14%

$59.39

Potential downside vs current price

Analyst Consensus

Hold18 analysts

Hold

Updated Jul 30, 2026

Total Analysts18

Buy

19

Hold

20

Sell

2

Ratings

Updated Jul 30, 2026

Overall Rating

B+

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score3.0 / 5

ROA Score4.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$64.66

Median Target-8.14%

$59.39

Potential downside vs current price